Arran Frood
From this contributor
Revised test offers reliable way to track autism over time
A recalibrated version of a widely used test for autism may accurately reflect autistic children’s development as they grow and become verbal.
Revised test offers reliable way to track autism over time
Games plus group therapy may help adults with autism find jobs
Adults with autism who undergo a therapy designed to bolster social learning show cognitive benefits that may increase their chances of employment.
Games plus group therapy may help adults with autism find jobs
Asbestos discovery ousts U.K. researchers from their labs
More than 1,500 people were forced to abandon labs and offices at the University of Oxford after a routine renovation revealed asbestos in a building.
Asbestos discovery ousts U.K. researchers from their labs
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.